Inceptor Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $21M

  • Investors
  • 2

Inceptor Bio General Information

Description

Operator of a biotechnology platform intended for advancing research and developing therapies to cure cancer. The company's platform identifies, incubates, and accelerates novel cell and genetic therapy technologies that maintain stemness and effector function within the tumor microenvironment to enhance immune cell performance and resistance to exhaustion, providing patients with improved cancer treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2450 Perimeter Park Drive
  • Suite 200
  • Morrisville, NC 27560
  • United States
+1 (919)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 2450 Perimeter Park Drive
  • Suite 200
  • Morrisville, NC 27560
  • United States
+1 (919)

Inceptor Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inceptor Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A2) 26-Feb-2025 $21M Completed Pre-Clinical Trials
3. Debt - General 22-Jul-2024 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 04-Mar-2022 $37.7M $41M Completed Pre-Clinical Trials
1. Seed Round 01-Jan-2020 $3.25M $3.25M Completed Pre-Clinical Trials
To view Inceptor Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Inceptor Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology platform intended for advancing research and developing therapies to cure cancer. The compan
Biotechnology
Morrisville, NC
23 As of 2026

San Diego, CA
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Inceptor Bio Competitors (3)

One of Inceptor Bio’s 3 competitors is Poseida Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Poseida Therapeutics Formerly VC-backed San Diego, CA
Carisma Therapeutics Formerly VC-backed Philadelphia, PA
Allogene Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 3 of 3 competitors. Get the full list »

Inceptor Bio Patents

Inceptor Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026047626-A1 Compositions and methods involving immune cells engineered for binding bispecific antibodies for use in cell therapy Pending 30-Aug-2024
WO-2025046513-A1 Methods of manufacturing myeloid-derived cells from hematopoietic stem cells and compositions and uses thereof Inactive 29-Aug-2023
AU-2024290220-A1 Compositions and methods for culturing t cells Pending 05-Jul-2023
EP-4739769-A1 Compositions and methods for culturing t cells Pending 05-Jul-2023
WO-2025008798-A1 Compositions and methods for culturing t cells Inactive 05-Jul-2023 C12N5/0636
To view Inceptor Bio’s complete patent history, request access »

Inceptor Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inceptor Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kineticos Life Sciences Management Venture Capital Minority
Next Coast Ventures Venture Capital Minority
To view Inceptor Bio’s complete investors history, request access »

Inceptor Bio Acquisitions (1)

Inceptor Bio’s most recent deal was a Merger/Acquisition with Arranta Bio (Process Development and GMP Clinical Manufacturing Business in Gainesville, Florida). The deal was made on 15-Nov-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Arranta Bio (Process Development and GMP Clinical Manufacturing Business in Gainesville, Florida) 15-Nov-2021 Merger/Acquisition Drug Discovery
To view Inceptor Bio’s complete acquisitions history, request access »

Inceptor Bio FAQs

  • When was Inceptor Bio founded?

    Inceptor Bio was founded in 2020.

  • Where is Inceptor Bio headquartered?

    Inceptor Bio is headquartered in Morrisville, NC.

  • What is the size of Inceptor Bio?

    Inceptor Bio has 23 total employees.

  • What industry is Inceptor Bio in?

    Inceptor Bio’s primary industry is Biotechnology.

  • Is Inceptor Bio a private or public company?

    Inceptor Bio is a Private company.

  • What is Inceptor Bio’s current revenue?

    The current revenue for Inceptor Bio is .

  • How much funding has Inceptor Bio raised over time?

    Inceptor Bio has raised $80.5M.

  • Who are Inceptor Bio’s investors?

    Kineticos Life Sciences Management and Next Coast Ventures have invested in Inceptor Bio.

  • Who are Inceptor Bio’s competitors?

    Poseida Therapeutics, Carisma Therapeutics, and Allogene Therapeutics are competitors of Inceptor Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process